⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for spiegelmer

Every month we try and update this database with for spiegelmer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic CancerNCT03168139
Metastatic Colo...
Metastatic Panc...
Olaptesed pegol...
Olaptesed pegol...
18 Years - TME Pharma AG
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated PatientsNCT04121455
Glioblastoma
Olaptesed pegol
Radiotherapy
Bevacizumab
Pembrolizumab
18 Years - TME Pharma AG
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated PatientsNCT04121455
Glioblastoma
Olaptesed pegol
Radiotherapy
Bevacizumab
Pembrolizumab
18 Years - TME Pharma AG
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic CancerNCT03168139
Metastatic Colo...
Metastatic Panc...
Olaptesed pegol...
Olaptesed pegol...
18 Years - TME Pharma AG
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)NCT01486797
Chronic Lymphoc...
NOX-A12
18 Years - TME Pharma AG
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: